SEC Form 4 · accession 0001127602-15-000579
CUBIST PHARMACEUTICALS INC · CBST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven C Gilman
Officer — EVP & Chief Scientific Officer
Period of report
Dec 31, 2014
Accepted (ET)
Jan 5, 2015 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000912183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2014 | J | 82 | $59.959 | A | 27,680 | D | |
| Common Stock | holding | — | — | — | 2,851 | I | 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares purchased pursuant to employee stock purchase plan.